Tag: atopic dermatitis

Tralokinumab Controls Moderate-to-Severe AD Over the Long Term

Tralokinumab (Adbry) was approved by the FDA in December 2021 for adult

Derick Alison Derick Alison

The Landscape of New Treatments for Eczema

MedPage Today brought together three expert leaders for a virtual roundtable discussion

Derick Alison Derick Alison

Staying Up-to-Date on Approved Therapies in Atopic Dermatitis

In this MedPage Today video, James Del Rosso, DO, of Touro University

Derick Alison Derick Alison

Clinical Challenges: Test Your Knowledge on Atopic Dermatitis

In a Clinical Challenges series on atopic dermatitis (AD), MedPage Today addressed

Derick Alison Derick Alison

Clinical Challenges: Atopic Dermatitis in Infants

A multifactorial disease, atopic dermatitis (AD) is the most common pediatric skin

Derick Alison Derick Alison

Transitioning Patients With Atopic Dermatitis From Topical to Systemic Therapy

At the recent 2023 Fall Clinical Dermatology Conference, several encouraging findings on

Derick Alison Derick Alison

Clinical Challenges: JAK Inhibitors for Atopic Dermatitis

The unprecedented number of targeted systemic therapies for moderate-to-severe refractory atopic dermatitis

Derick Alison Derick Alison
adbanner